Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE925
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,358
Award facts
- Contract value 100% obligated
- $18,357.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,357.85 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the underlying vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor providing critical medical commodities across multiple therapeutic domains to federal agencies, particularly the Department of Defense and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for DESCOVY, an antiretroviral medication, reflects the contractor's ongoing role in supplying essential pharmaceutical products to support military and federal healthcare operations. All awarded contracts through this vehicle have been competitively awarded with firm fixed-price terms, demonstrating the contractor's capability to meet federal procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FE925?
SPE2DR26FE925 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FE925 worth?
The government has obligated $18,358 on SPE2DR26FE925.
Is contract SPE2DR26FE925 an order under another contract?
Yes. SPE2DR26FE925 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE925 competed?
The extent of competition for SPE2DR26FE925 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award